CAROLINE MANSY: Open Payments
NPI 1467457622 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$13,738 in 43 payments from 8 companies in 2025. Trend: 2023 $27,380 · 2024 $20,867 · 2025 $13,738
Speaker / faculty: $10,717Travel & lodging: $2,075Food & beverage: $946
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 22 | $6,905 |
| Novo Nordisk Inc | 7 | $6,454 |
| Dexcom, Inc. | 7 | $157 |
| CeQur Corporation | 1 | $63 |
| Insulet Corporation | 2 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $56 |
| Medtronic, Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $22 |
Products named: Ozempic, MOUNJARO, Dexcom G6 Transmitter, ZEPBOUND, CeQur Simplicity, Omnipod, Kerendia, INTELLIS ADAPTIVESTIM.
Industry payments across MD — which companies pay providers there.
